Apellis Pharmaceuticals, Inc. which can be found using ticker (APLS) now have 15 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between 156 and 76 and has a mean target at $103.53. Now with the previous closing price of $88.11 this is indicating there is a potential upside of 17.5%. There is a 50 day moving average of $76.43 and the 200 day MA is $61.52. The total market capitalization for the company now stands at 10.21B. The current stock price for Iron Mountain Incorporated is currently 87.68 USD
The potential market cap would be $11,997,953,336 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 0.96 and a -37.69% return on assets.
